LOS ANGELES — Week three of the Johnson & Johnson talc powder trial opened Monday, as the company’s defense team painted the plaintiff’s disease expert as only having formed his opinion that talc could cause cancer after being hired by plaintiff’s lawyers to testify against the company.
Epidemiologist Jack Siemiatycki agreed with Proskauer Rose defense attorney Manuel Cachán during cross-examination in the Los Angeles Superior C...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In